oka
Start 7-day trial
Investor directory

Forbion

VC fundNaarden, Netherlandsforbion.comLinkedIn

Forbion integrates ESG principles into its investment strategy while focusing on biotech innovations that improve health outcomes.

What they invest in

Stages

Pre-SeedSeedSeries AGrowthSeries B

Sectors

Biotech & PharmaClimateHealthTechImpact

Geographies

NetherlandsGermanyUnited States

In numbers

In the last 24 months, Forbion took part in 17 funding rounds on record at Oka, 7 of them in the last 12 months. It led or co-led 10 of the 17 rounds where the lead investor was reported. HealthTech is its most frequent sector (10 of 17 rounds with a known sector), Series A its most frequent stage (8 of 17). Most often the startup was based in the United States: 6 of 16 rounds with a known location. The most recent round on record is from October 2026.

As of October 2026. Source: Oka, counted from funding rounds reported in the press; rounds that were never reported are not included.

The facts

Typical cheque
€200k – €1.5M
Headquarters
Naarden, Netherlands
Founded
2000

Portfolio companies

AAVantgarde BioAzafarosCellCentricCitryll -CoultreoneedenElevara MedicinesGenominesGranite Bio AGLoQus23Mestag TherapeuticsNoema PharmaNumabOrbis MedicinesPurespring TherapeuticsRQ BioSidera BioSynOxTropic BiosciencesVerdiva Bio

More portfolio companies

Damora Therapeutics (Biotechnology) (NAS: DMRA)EnGene Therapeutics (NAS: ENGN)Braveheart BioAM-PharmaBeacon TherapeuticsVectorY TherapeuticsCoultreon BiopharmaBioInvent International (STO: BINV)SideraMapLight Therapeutics (NAS: MPLT)Calluna PharmaPrileniaInflazomeCapstan TherapeuticsKynexisGyroscopeAiolos BioMilestone Pharmaceuticals (NAS: MIST)Dyne Therapeutics (NAS: DYN)AIRNAHookipa Pharma (OTCM: HOOK)F2GMariana OncologycAMPfield Therapeutics

and 18 more

Recent rounds

  • OMass Therapeutics

    €275 millionSeries CBiotech & Pharma

    Bain Capital Life SciencesleadForbionleadNovo HoldingsleadJanus Henderson InvestorsSV Health InvestorsJefferson Life Sciences · +5 more in the source

    UKeu-startups.com

  • MapLight Therapeutics

    $372.5 millionSeries D+HealthTech

    Forbionlead · +1 more in the source

    United Statesnews.crunchbase.com

  • Azafaros

    €132MSeries BHealthTech

    Forbion GrowthleadJeitoleadForbionSchrodersBioGeneration Ventures · +2 more in the source

    Netherlandssiliconcanals.com

  • eeden

    €18MSeries AClimate

    ForbionleadNRW.VentureHenkel VenturesD11ZTechVision Fonds · +1 more in the source

    Germanysiliconcanals.com

  • Verdiva Bio Limited

    $411MSeries ABiotech & Pharma

    ForbionleadGeneral AtlanticleadOrbiMedLogos CapitalLilly Asia VenturesLYFE Capital · +1 more in the source

    United Kingdomsiliconcanals.com

Rounds Forbion took part in, as reported by the linked articles. See who else is investing right now.

Questions founders ask

Is Forbion actively investing?
Yes. Oka has 7 funding rounds with Forbion on record from the last 12 months; the most recent is from October 2026.
Does Forbion lead rounds?
Forbion led or co-led 10 of the 17 rounds on record where the lead investor was reported (last 24 months).
How much does Forbion typically invest?
Forbion states a typical cheque of €200k – €1.5M.
Which stages does Forbion invest in?
Forbion invests at Pre-Seed, Seed, Series A, Growth and Series B. In the rounds on record, Series A is the most frequent (8 of 17).
Where is Forbion based?
Forbion is headquartered in Naarden, Netherlands.

Does Forbion fit your round?

In 30 minutes you'll know which funds matter for your round.

Get a demo

Search investors like this in Claude — no account, no sign-in. Open in Claude

Are you Forbion? Tell us what to correct and we will update it — or ask us to remove the entry.